Remedy Pharmaceuticals Secures $500,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5914b6db-fca1-476f-801b-6be6985a6206&Preview=1
Date
11/22/2011
Company Name
Remedy Pharmaceuticals
Mailing Address
Undisclosed New York, NY 10001
Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
Website
http://www.remedypharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended.
M&A Terms
Venture Investor
Undisclosed